Search

Search Constraints

You searched for: Author/Creator Grupp, Stephan A

Search Results

1. CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials. Issue 10 (October 2021)

3. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. Issue 5 (May 2023)

4. Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. Issue 12 (December 2019)

5. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. Issue 8 (5th August 2021)

7. Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells. Issue 5 (18th May 2021)

8. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events. Issue 2 (16th December 2020)

9. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. (4th November 2015)